Deferred Tax Assets, Net of Valuation Allowance of Edesa Biotech, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
Edesa Biotech, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Edesa Biotech, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 30 Sep 2025 was $131,000, a 4% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)

Edesa Biotech, Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $131,000 +$5,000 +4% 30 Sep 2025 10-K 12 Dec 2025 2025 FY
Q3 2024 $126,000 -$107,000 -46% 30 Sep 2024 10-K 12 Dec 2025 2025 FY
Q3 2023 $233,000 +$197,000 +547% 30 Sep 2023 10-K 13 Dec 2024 2024 FY
Q3 2022 $36,000 -$8,000 -18% 30 Sep 2022 10-K 15 Dec 2023 2023 FY
Q3 2021 $44,000 -$58,000 -57% 30 Sep 2021 10-K 16 Dec 2022 2022 FY
Q3 2020 $102,000 +$102,000 30 Sep 2020 10-K 28 Dec 2021 2021 FY
Q3 2019 $0 30 Sep 2019 10-K 07 Dec 2020 2020 FY
Q4 2018 $0 31 Dec 2018 10-KT 12 Dec 2019 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.